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Summary
Introduction: Medium-term studies of ABG-1TM cementless total hip arthroplasty have shown
favorable functional results with excellent femoral component ﬁxation but an abnormally high
rate of periacetabular component osteolysis, which may require early revision.
Hypothesis: The periacetabular osteolysis rate increases with time with the ABG-1TM implant,
leading to a high revision rate.
Objective: The objective of this study was to test this hypothesis with a minimum follow-up
of 10 years and evaluate the progression of periacetabular osteolysis and its consequences on
implant ﬁxation.
Material and methods: A continuous series of 111 ABG-1TM cementless prostheses implanted
by a single operator with a theoretical minimum follow-up of 10 years. Seventy-ﬁve implants
were analyzed with a mean follow-up of 13 years. All the prostheses had been implanted via
a posterolateral approach and consisted of a 28mm cup matching a head in zirconia and an
antidislocation rim design high-density polyethylene insert.
Results: Twelve cups were revised because of progressive retroacetabular osteolysis. The
revisions were performed systematically although there was no pain or gross cup loosen-
ing. The revisions included resection of the granuloma, cavity ﬁlling with morselized bone
grafts, and implantation of new uncemented ABG-2TM cups in eight cases or cemented
cups associated with a support ring in the four other cases. Thirty-two (48.5%) of the
cups still in place at the end of the follow-up evaluation presented moderate and asymp-
tomatic radiographic osteolysis, inciting close subsequent observation. No predictive factor
of osteolysis onset was identiﬁed (age, body mass index, polyethylene wear, or cup ori-
entation). None of the femoral stems was changed because of osteolysis: the only two
femoral revisions resulted from periprosthetic fracture and one case of bipolar loosening.
DOI of original article:10.1016/j.rcot.2009.09.026.
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The femoral osteolysis images were small and all limited to zones 7a (18.8% of cases), 1a, and
1b (65.2% of cases). The overall survival rate of the series at 13 years of follow-up was 80.5%;
the cup survival rate was 83.2%; the femoral implant, 94.3%; and failure of the femoral stem
secondary to aseptic loosening was only 1.3%.
Discussion, conclusion: This long-term study conﬁrms the high frequency of retroacetabular
osteolysis of ABG-1TM prostheses surpassing the osteolysis rate of other uncemented cups with
a polyethylene insert. The absence of predictive criteria of osteolysis occurrence and the lack
of symptoms warrants periodic follow-up of patients with ABG-1TM cups and, if necessary, early
repair of bone stock loss with grafts combined with acetabular cup revision. This procedure
remains simple as long as performed before the onset of massive bone destruction, conﬁrming
the proposed revisions in this series were judicious. This study also conﬁrms the excellent long-
term ﬁxation of the ABG-1TM femoral stems derived from the osteointegration and proximal
seal around the hydroxyapatite
Level of evidence: Level IV: ret
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implanted were in zirconia andmeasured 28mm in diameter.
Operative techniquentroduction
he cementless ﬁrst-generation anatomic Benoist Girard
otal hip prosthesis (ABG-1TM) was introduced and widely
mplanted in Europe beginning in 1989. Several series
eported good short- and medium-term results with these
mplants [1—10], but to our knowledge, no study has
eported results with a minimum follow-up of 10 years.
illiam Harris [11] suggested that the main factor in
ementless implant failure was osteolysis. The ABG-1TM
rosthesis was unfortunately no exception in the above-
entioned series [1—10]: they present a high rate of cup
ailure but a long-lasting ﬁxation and better survival for
he stems. The objective of this study was to determine
hether the frequency of osteolysis observed with the ABG-
TM implants worsened with time and whether they were
esponsible for an increase in the number of revisions and
oosening beyond 10 years. To test this hypothesis, we con-
ucted a clinical and radiographic analysis of a continuous
eries of ABG-1TM prostheses implanted by the same opera-
or, with a minimum follow-up of 10 years.
aterial and methods
atients
he continuous series included 111 total hip arthroplasties
THAs) with implantation of the ABG-1TM system, performed
y a single senior operator (G.A.), in 101 patients (ten bilat-
ral implantations). A single implant model was retained for
ll patients during this period from January 1990 to Decem-
er 1994. A total of 53 women (57 THA) and 48 men (54 THA)
ere treated. The inclusion criteria in this retrospective
tudy were a minimum radiographic and clinical follow-up
onger than 10 years.
At revision, 19 patients (21 THAs) had died of causes
ndependent of the arthroplasty before this follow-up time,
4 patients (14 THAs) had been lost to follow-up, and one
atient refused to be seen (implant still in place). Six
atients with their prosthesis still in place were contacted
y telephone because of poor general health. The clinical
nd radiographic review was carried out by an observer
ho had not participated in the interventions (B.R.) for
9 THAs and by telephone questionnaire for six THAs. This
A
v
icoating.
rospective therapeutic study.
sson SAS.
eries studied 75 THAs, divided into 46 THA right and 29 left
HAs. The mean age of the patients at implantation was
3.1 years (range, 33—83); their body mass index (BMI) was
5.3± 3.4 kg/m2 (range, 17.3—32.8).
These arthroplasties were performed in 38 cases for
rimary coxarthrosis, in three cases for rapid destructive
oxarthrosis, in six cases for rheumatoid arthritis, in nine
ases for aseptic necrosis of the femoral head, in 12 cases
or arthrosis secondary to hip dysplasia, in four cases for
osttraumatic osteoarthritis, in two cases for congential hip
islocation sequelae, and in one case for consersion of a hip
usion.
mplants
he ABG-1TM acetabular component is designed as a hemi-
phere in a titanium alloy with 12 holes for increased primary
tability by added screws or spikes. Its hydroxyapatite (HA)
oating provides medium- and long-term secondary stability
o the implant through its osteointegration properties. It was
mplanted in 72 cases. In three cases, a cementless threaded
up (TitanTM, Depuy-Landanger, UK) was put in place. How-
ver, to present a homogenous series of ABG-1TM acetabular
mplants, these three threaded cups were removed from the
linical and radiographic analyses. All the polyethylene (PE)
nserts of the ABG-1TM cup used weremade in high-density PE
ith an antidislocation rim impacting in this metal-backed
up with a two-‘‘olive’’ blocking system.
The ABG-1TM femoral component was also made of tita-
ium alloy coated with HA on its metaphyseal proximal third
or secondary biological anchoring. Its anatomic design char-
cterized by anteroposterior curvature straightened on its
istal part can provide a 135◦ cervical-diaphyseal femoral
ngle, 5◦ antetorsion, and 7◦ anteversion. The metaphy-
eal part was covered with scales on its anterior, posterior,
nd medial sides to increase the implant’s primary stabil-
ty. It was implanted in all patients. All the prosthetic headsll surgeries were performed following the same technique
ia the posterolateral approach with the patient positioned
n lateral decubitus, with repair of the posterior capsule and
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the dorsal hip muscles. The ABG-1TM cementless acetabular
implant was impacted after avivement of the acetabulum
in subchondral bone; the cup orientation reproduced the
orientation of the acetabulum. Two spikes or screws, in
the superior polar position, were added systematically to
increase primary stability. Before implanting the femoral
component, the medullary canal was reamed to a dimension
1mm greater than the stem caliber, followed by preparation
with speciﬁc rasps progressively increasing in size, system-
atically beginning with the smallest (size 1) and pushing
the rasp shoulder into the trochanteric fossa until perfect
rotatory stability was achieved. Associated procedures were
performed in eight cases: four acetabular shelf acetabulo-
plasties, two ablations of former ﬁxation devices, and two
releases of the hip adductor muscles. Antibiotic therapy
was provided postoperatively for 48 h. Preventive measures
against heterotopic ossiﬁcations were not taken systemati-
cally. Full weightbearing was allowed the day after surgery,
supervised by a physical therapist.
Evaluation method
The clinical and radiographic review was carried out by an
observer that did not participate in surgery (B.R.). Preop-
erative assessment and then at revision used of the Postel
Merle d’Aubigné (PMA) score [12] and the Harris Hip Score
[13] as well as the Charnley function classiﬁcation [14].
The radiographic parameters were analyzed on the AP
pelvic images with load and on AP and lateral images of
the prosthetic hips taken preoperatively, at the 3rd month
postoperative, and at the latest follow-up. The femoral mor-
phology was studied using the classiﬁcation provided by
Noble et al. [15]. Femoral metaphyseal ﬁlling was stud-
ied on AP hip X-rays taken immediately after surgery and
femoral implant centering was measured. On the latest
follow-up images, acetabular inclination, heterotropic ossi-
ﬁcation according to Brooker et al. [16], periacetabular
osteolysis according to De Lee and Charnley [17] and femoral
osteolysis classiﬁed according to Gruen et al. [18], stress
shielding, and cancellous densiﬁcation were all studied. Sta-
bility and implant ﬁxation were evaluated using the ARA
score [19] and Engh et al. [20] parameters. PE insert wear
was measured using the technique reported by Livermore
et al. [21], which was also used to calculate annual linear
wear (ALW) corresponding to the total linear ratio measured
divided by the time to onset of this wear.
All the results are expressed in mean values± standard
deviation. The survival curve was determined using the
Kaplan-Meier method [22] with a 95% conﬁdence interval.
We deﬁned failure as surgical revision of the prosthesis
for any cause. For the statistical analyses, the Student t-test
was used to compare the clinical and radiologic data. The
signiﬁcance threshold was set at 0.01.
ResultsComplications
Three early complications occurred in three patients:
(a) one deep hematogenous alphahemolytic Streptococcus
infection successfully treated with surgical debridement,
c
(
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reservation of the implants in situ, and adapted antibiotic
herapy for 3months. (b) Obturator neuralgia was treated
y neurolysis of the obturator nerve. Pain persisted despite
lear early clinical improvement. (c) Finally, a Vancouver
L periprosthetic femoral fracture at the 3rd postopera-
ive month in a 65-year-old patient was treated surgically
ith bone cerclage and preservation of the femoral implant
n situ. Later progression was satisfactory with osteoin-
egration of the stem after a stem subsidence of 6mm
urther and stabilizing it. However, no intraoperative, sci-
tic neurapraxia, or postoperative hematoma complication
as encountered.
Eight late complications occurred in seven patients.
a) Six patients experienced dislocations (8%) after a
ean 31.5months after implantation, all in the poste-
ior direction. Orthopaedic treatment with no recurrence
as achieved in three cases, and recurring instability in
he three other cases required secondary treatment: an
solated change of the prosthesis head with no other pro-
edure on the implants left in place in two cases, at the
5th and 18th postoperative month, and one cup change
o reposition the implant in one case, at the 112th post-
perative month. The severity of the wear, inclination,
up diameter, head/cup diameter ratio, and the number
f interventions on the hip before the ﬁrst implantation
id not inﬂuence dislocation occurrence. (b) One acetab-
lar periprosthetic fracture in a 77-year-old patient after
fall, 11 years after implantation. This was a transver-
al fracture with little displacement of the acetabulum
nd no cup destabilization, treated orthopaedically with
o later complications. (c) One traumatic periprosthetic
emoral Vancouver B2 fracture in an 82-year-old patient at
2.5 years, treated by changing the femoral component with
steosynthesis.
mplant changes
e report a total of 14 cup changes ABG-1TM. (a) Twelve of
hem involved retroacetabular osteolysis. The patients pre-
ented no pain or implant migration. These revisions were
ade on ﬁve men and seven women, 58.1± 14.9 years of
ge (range, 33—76) at implantation, with a mean follow-
p of 131± 35months (range, 60—180). Cup inclination
as a mean 45.1◦ ± 2.1◦ (range, 38—52) and the wear
ate was 0.21± 0.05mm/year (range, 0.12—0.36). Second-
eneration cementless ABG-2TM cups were implanted
eight cases) and support rings with a cemented PE cup
four cases). (b) One case presented recurring instabil-
ty (explained above) requiring cup repositioning at the
12thmonth after surgery. (c) The last case involved asep-
ic loosening with cup migration, making this a bipolar
mplant failure, with onset 40months after conversion of
hip fusion in a young (43 years), highly active patient.
n this revision, a new ABG-1TM acetabular prosthesis was
mplanted.
Two femoral components had to be changed, in one
ase for a Vancouver B2 periprosthetic femoral fracture
see above), and for the bipolar aseptic loosening occur-
ing after the conversion of the fusion explained above. The
emoral stem was replaced by a cemented reconstruction
tem.
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Table 1 Preoperative and revision Postel Merle d’Aubigné
(PMA) [12] and Harris [13] parameter scores.
Mean scores Preoperative At revision P
Overall PMA 11.8 ± 2.3 16.3 ± 1.7 p < 0.01
PMA pain 2.7 ± 1.3 5.5 ± 0.8 p < 0.001
PMA mobility 4.9 ± 1.4 5.8 ± 0.4 p < 0.01
PMA activity 4.2 ± 0.8 4.8 ± 1 p < 0.01
Overall global 56.7 ± 12.4 87.3 ± 10.7 p < 0.001
Harris pain 19.9 ± 7.5 40.6 ± 5 p < 0.001
Harris mobility 3 ± 1.2 4.2 ± 0.8 p < 0.01
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Early implant migration was observed in one case, in aHarris activity 8.3 ± 1.4 11.2 ± 2.1 p < 0.001
Harris walking 22.3 ± 6.2 27.5 ± 5.7 p < 0.001
linical results
f the 75 hips included with a minimum follow-up of 10 years
nd a mean follow-up of 13± 2 years (range, 10—17), the
ean PMA score [12] rose from a preoperative mean of
1.8± 2.3 to 16.3± 1.7 at the last follow-up (p < 0.01)
nd the Harris score [13] progressed from 56.7± 12.4 to
7.3± 10.7 (p < 0.001). The speciﬁc parameters of these
cores are detailed in Table 1. Pain showed the most sig-
iﬁcant improvement. No thigh pain was reported.
From a functional point of view, the patients’ capacities
hanged, with an increase in the number of joint involved
ccording to Charnley [14], as shown by the signiﬁcant dif-
erences in distribution between the preoperative and last
ollow-up state (Table 2).
adiological results
cetabular implants
f the 69 complete radiological ﬁles studied, with the
xception of the three TitanTM cups, 66 ABG-1TM cups and 69
emoral components were implanted. At revision, the mean
up inclination was 45.5± 6◦ (range, 28◦—60◦). Heterotopic
ssiﬁcations were found in 30 cases (43.4%), divided accord-
ng to Brooker et al. [16] into type 1, 20 cases; type 2, three
ases; and type 3, seven cases.
All the cups presented signs of radiographic osteointe-
ration. One cup presented an equatorial radiolucent line,
ess than 2mm, in De Lee and Charnley [17] zones 1 and 3.
hirty-two cups (48.5%) presented retroacetabular osteoly-
is. For these implants, the mean inclination was 44.8± 5◦
range, 28◦—60◦), the mean patient age at implantation was
3.4± 7.9 years (range, 34—82), there were 14 women and
8 men with a mean BMI of 25.6± 2.1 kg/m2 (range, 22—32),
nd the mean PE wear measured was 0.17mm/year± 0.06
range, 0.07—0.44). These parameters did not differ from
w
t
i
o
Table 2 Preoperative and revision Charnley [14] functional distri
Charnley functional class Number of cases, preoperativ
A 37
B 34
C 4R. Bidar et al.
he rest of the population studied and their statistical anal-
sis did not allow us to correlate them with the onset
f osteolysis. Study of the De Lee and Charnley zones
howed osteolysis in 16 cases (24.2%) in zone 1, in 22 cases
33.3%) in zone 2, and in four cases (6.1%) in zone 3. All
he other implants were considered stable according to
ngh et al. [20]. The mean annual PE wear in the series
as 0.16mm/year± 0.07 (range, 0.05—0.44). In 19 cases
28.8%), it was considered substantial (> 0.2mm/year).
emoral implants
he preoperative morphological study of the implanted
emurs found a normal femoral canal ﬂare in 79.7% of cases
nd a cylindrical canal in 20.3%, according to Noble et al.
15]. Appropriate metaphyseal sizing of the stems was found
n 72.4% of the cases, with the implant ﬁlling the proximal
emur metaphysis between 80 and 90%. Undersizing (meta-
hyseal ﬁlling < 80%) was reported in 13.8% of the cases and
versizing (metaphyseal ﬁlling > 90%) in 13.8% of the cases.
n three cases (4.4%), a varus position greater than or equal
o 5◦ was noted. No valgus position greater than or equal to
◦ was observed.
Our study demonstrated no correlation between corti-
al ﬂare, implant position, and implant size. These three
arameters were not inﬂuenced by age, sex, BMI, and
he patients’ Charnley score before implantation. Sixty-ﬁve
tems (95.6%) presented cancellous densiﬁcation, creating
potwelds oriented diagonally from top to bottom between
he implants and the femoral cortices, distributed, accord-
ng to Gruen et al. [18], in zones 2 for 64 stems (92.7%),
n zone 6 for 65 stems (94.2%), in zones 3 for 23 stems
33.3%), and in zone 5 for 22 stems (31.9%). Twelve stems
17.4%) presented condensations perpendicular to the stem
upport, in zone 1b. Forty-four hips (63.8%) showed calcar
trophy, for the most part moderate, most often located
n zone 7a. Proximal stress shielding, at the level of the
reater trochanter, was reported for 25 hips (36.2%). Cor-
ical thickening was noted in 19 cases (27.5%). It was
resent simultaneously in zones 3 and 5 in 10 cases and
as isolated in zone 3 in seven cases and in zone 5 in
wo cases. Our statistical analysis did not correlate corti-
al thickening with metaphyseal sizing and femoral stem
osition. Reactive lines were observed for 29 cases (42%),
ut only in the smooth zones that were not coated with
A. Twenty-six cases (37.7%) had a stable pedestal (with
o adjacent radiolucent line as described by Engh et al.
20]). Its presence was not correlated with reactive lines
p < 0.01).oman who presented a Vancouver AL femoral peripros-
hetic fracture that was ﬁxed without changing the femoral
mplant, at the 3rd postoperative month. One case of radi-
lucent line in zones 2 and 7, with no stem destabilization,
bution of patients.
e Number of cases, revision P
6 p < 0.001
45 p < 0.001
24 p < 0.001
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Figure 1 Survival curve of ABG-1TM cups. End-point criterion: cup revision for any reason.
End-p
8
8
D
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i
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r
HFigure 2 Survival curve of ABG-1TM stems.
was noted during implantation in a 72-year-old patient who
had had a cup change at the 106th month after surgery.
Perifemoral osteolysis was observed on X-rays. This
involved granulomas concentrated in the metaphyseal zones
only, with no diaphyseal extension. They were observed in
zone 1a, occasionally in zones 1a and 1b, in 65.2% of the
cases, and in zone 7a in 18.8% of the cases. No distal oste-
olysis underlying the osteointegration zone related to the
presence of HA coating was observed.Survival analysis
At 13 years, the implant survival rate, calculated using the
Kaplan-Meier method [22] with a 95% conﬁdence interval,
was 80.5% (range, 70.8—91.5) for the overall series. It was
e
f
i
t
roint criterion: stem revision for any reason.
3.2% (range, 74—93.5) for the cup (Fig. 1) and 94.3% (range,
8—100) for the stem (Fig. 2).
iscussion
everal authors have already evaluated the ABG-1TM
mplants at the medium term [1—10]. They agree on the
ood clinical and radiological results, including notably the
egular presence of good osteointegration on the images.
owever, Blacha [6] and Delank et al. [7] demonstrated
xcessive PE wear. A large number of acetabular revisions
or PE wear and pelvic osteolysis had already been reported
n a medium-term series [6,7,10], leading these authors
o abandon the ABG-1TM cup and to recommend increased
adiological monitoring of patients who had received these
584 R. Bidar et al.
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migure 3 Marking from the screw holes on the polyethylene
nsert explanted 13 years after implantation.
mplants. At 13 years of follow-up, our series also conﬁrms
he high proportion of pelvic osteolysis (48.5%), although
ith no cup destabilization at the long term.
The appearance of osteolysis is multifactorial: among the
nﬂuential factors, the modularity of the implant is a deter-
ining factor. Indeed, Fehring et al. [23] as well as Young
t al. [24] estimated that this osteolysis can lead to a prob-
em of the insert in PE conforming to the metal-back. If this
eans a dissatisfactory insert blocking system, particularly
n rotations [24,25], a micromobility between the prosthetic
omponents is present at this interface and produces abra-
ive wear of the PE on the internal part of the metal-back.
he ABG-1TM cup blocking system, with two ‘‘olives,’’ could
e considered insufﬁcient and was modiﬁed in the ABG-2TM
econd-generation implants that appeared in October 1996.
his wear can also be increased by the presence of screw
oles [25,26] (Fig. 3). For Aspenberg et al. [27] and Young
t al. [24], this micromobility in the acetabular compo-
ent allows drainage of the joint space ﬂuid loaded with PE
ebris. During hip movements, a pumping mechanism is cre-
ted that expels this ﬂuid under pressure, through the screw
oles of the metal-back, thus creating the formation of lytic
ranulomas. For Barrack et al. [26], this phenomenon seems
ncreased by the presence of screws inserted to stabilize the
up during initial implantation.
In this series, the systematic use of a PE insert with
n antidislocation rim can also be blamed for the onset
f osteolysis lesions. For Herrera et al. [10], this fea-
ure is responsible for additional PE wear from a posterior
mpingement between the prosthetic femoral neck and this
im. Examination of our explants conﬁrms this theory, with
he presence of a notch on the rim (Fig. 4). Moreover,
hese repeated posterior contacts can produce an abnor-
al movement of the prosthetic head within the insert, thus
ncreasing its wear as well as the movements between the
nsert and the metal-back [28].
The characteristics of the PE insert itself can also be
lamed in the onset of osteolysis. Gamma irradiation ster-
lization in ambient air causes the PE to reticulate but
ncourages the creation of free radicals and its oxidation,
ssentially in its discharged zones [29—31], thus reducing its
uality and mechanical resistance [32,33] to the penetra-
c
t
cigure 4 Wear on the antidislocation rim from posterior
mpingement on an insert removed 13 years after implantation
see the spike at the bottom of the cup).
ion of the prosthetic head. The systematic use in our series
f 28mm zirconia heads may also have been the source
f greater insert wear [34], attributable to an increase in
oughness and the loss of head sphericity at the medium
erm, as also reported by Hernigou et al. [35] upon explant
xamination.
The high PE wear rate (mean ALW=0.16mm/year)
bserved in our study may also have contributed to the high
requency of osteolysis lesions. Schytzer et al. [36] proved
hat for a mean ALW greater than 0.1mm/year, osteolysis
as systematically present. Some authors [26,28,37] indi-
ate that the follow-up has an incidence on visualizing these
ranulomas, which are very rarely detected before the 4th
ear [26] and are revealed increasingly beginning in the 5th
ostoperative year [28,37]. The possibility of accentuated
E wear caused by a ‘‘third body’’ —debris of HA particles
eleased in the prosthetic joint at the cup—head interface
uring implant impaction— advanced by Morscher et al. [38]
nd Castoldi et al. [9] was later disproved. Increased PE wear
as ﬁnally related to patient factors such as age, sex, and
eight [39,40], as well as the surgical technique such as cup
osition [41] and the thickness of the PE used [11,41,42]. Our
tudy has not been able to conﬁrm these notions.
Depending on the severity of the lesions, the cup model,
nd the head bearing system, treatment of pelvic osteoly-
is is difﬁcult to resolve. Given the difﬁculty in extracting
mplants and the substantial damage caused, some authors
ave proposed isolated changes of the prosthesis bearing
ystem [43,44] with or without ﬁlling the osteolytic lesions.
ther authors have suggested cementing a new PE insert
ithin metal-back cups left in place [45,46]. This thera-
eutic solution was not retained in our experience and we
ecided to remove the cup each time because of the ease
f extracting it so as to clean out and ﬁll the lesions with
orselized bone grafts, which explains the high rate of cup
hanges in our series. Replacing these implants with an unce-
ented cup of a slightly larger diameter allowed us to come
lose to a primary implant technique (Fig. 5A—C).
The quality of the ABG-1TM femoral implant osteointegra-
ion observed in this series was very satisfactory (a single
ase of aseptic implant loosening). This can be explained
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CT scan of retroacetabular osteolysis. C. Image 2 years after the
by the anatomic design of the implants and the use of HA
coating. For Vidalain [47], the essential condition to obtain
implant osteointegration is obtaining faultless primary sta-
bility. This is encouraged by the anatomic design of the
ABG-1TM femoral stem in which its conformation and diaphy-
seal reaming of the femur at implantation provided ensured
stability only in the metaphyseal zone. Femoral ﬁlling and
stem positioning did not seem to inﬂuence the implants’
osteointegration in our study.
Moreover, the use of HA as a bioactive material to ensure
secondary bone anchorage of the implants has shown its
innocuousness in terms of inﬂammation, allergy, toxicity,
and carcinogenicity [48,49]. Bone remodeling at contact
with an implant coated with HA begins in the 3rd postopera-
tive week, without ﬁbrous material intervening between the
host bone and the prosthesis, according to Hardy et al. [50].
This osteointegration took place for all ages of patients,
hip arthrosis etiologies, implanted femur morphology, proxi-
mal femoral metaphyseal ﬁlling, and implant position in our
series. This association of a HA coating and the anatomic
design of the femora stem ensure long-term suitable trans-
mission of the stress forces in the implanted bone with no
impingement or diaphyseal intolerance. No thigh pain was
found in this study.
The appearance of bone bridges (spotwelds), charac-
terizing this osteointegration, in zones 3 and 5 are a
demonstration of this progressive passage of stress forces
between the implant and the bone over time, as previously
reported by Tonino et al. [3,4] and Herrera et al. [10]. These
authors report that osteointegration began in a high meta-
physeal zone, in the ﬁrst years after implantation, then
migrated toward lower metaphyseal zones, following the
5th year after implantation, without going beyond the lower
limit of the HA coating.
This transfer of the proximal forces into distal forces on
the femur can be associated with different bone modiﬁca-
tions on the radiographs. Cortical thickening was found in
R
A
u
Tene wear and retroarticular osteolysis requiring cup change. B.
nge to a ABG-2TM cup preserving the ABG-1TM femoral implant.
he relatively early postoperative period in the diaphyseal
one (27.5%) in our series. It is generally present in Gruen
ones 3 and 5 [18] but absent on lateral images. It can be
onocortical over the short term, depending on the implant
osition, but it progressively disappears at the medium term
nd does not indicate a conﬂict between the stem’s tail
nd the bone, nor inappropriate implant size, according to
onino et al. [3]. In our study, the presence and location
f this cortical thickening were not correlated with over-
izing or femoral implant position. Proximal stress shielding
an frequently be observed, in 55—74% of cases, depend-
ng on the series, at the medium and long term [1,7]. It
an result from a number of conditions: preoperative bone
ensity, funnel-shaped femur morphology, implant position,
nd transfer of forces [7]. Our series demonstrated no rela-
ion between this phenomenon of bone demineralization
nd these parameters. The absence of thigh pain at follow-
p conﬁrms the primary stability and the osteointegration
apabilities of the ABG-1TM implant.
The presence of clearly delimited osteolytic lesions,
ocated only on the intra-articular femoral part (in zones 1a
nd 7a), stopped by horizontal trabecula at the implant’s
houlder (zone 1b) and diagonal in zone 7b, where the
mplant’s HA coating begins, demonstrate sealed circumfer-
ntial osteointegration of the implant to the bone, acting
ike a barrier preventing any distal migration of PE wear
articles in the gap zones [4]. This series showed no major
roximal osteolysis of the femur and no osteolysis around
he implant in the diaphyseal zone.
onclusioneporting the long-term clinical and radiological results of
BG-1TM implants used in primary implantation for THAs
nderscores the frequency of retroacetabular osteolysis.
he lack of predictive criteria for its occurrence and the
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ack of symptoms encourages us to propose regular monitor-
ng of these patients after 10 years of implantation as well as
arly preventive acetabular revision when progressive oste-
lysis occurs. The cup extraction technique is simple, since it
aves bone stock and therefore, in most cases, allows place-
ent of a new cementless cup. This study also conﬁrms
he excellent long-term stability of the ABG-1TM anatomic
emoral stems and the advantages of its use for any qual-
ty of femur bone, in both the young active subject and the
lder osteoporotic patient.
onﬂicts of interest
. Asencio: Conferences, invitations by Stryker as a speaker.
ember of the design group for the ABG system since 2006.
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